Leadless Pacemakers: State of the Art and Future Perspectives

Domenico G. Della Rocca; Carola Gianni; Luigi Di Biase; Andrea Natale; Amin Al-Ahmad

doi:10.1016/j.ccep.2017.11.003

Leadless Pacemakers: State of the Art and Future Perspectives

Domenico G. Della Rocca, Carola Gianni, Luigi Di Biase, Andrea Natale, Amin Al-Ahmad

Medicine

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Leadless pacemaker therapy is a new technology that aims at avoiding lead- and pocket-related complications of conventional transvenous and epicardial pacing. To date, 2 self-contained leadless pacemakers for right ventricular pacing have been clinically available: the Nanostim Leadless Pacemaker System and the Micra Transcatheter Pacing System. Additionally, a new multicomponent leadless pacemaker for endocardial left ventricular pacing has been proposed as an alternative choice for cardiac resynchronization therapy. In this review, we describe the state of the art of leadless pacing and compare the currently available devices with traditional transvenous leadless pacemakers.

Original language	English (US)
Pages (from-to)	17-29
Number of pages	13
Journal	Cardiac Electrophysiology Clinics
Volume	10
Issue number	1
DOIs	https://doi.org/10.1016/j.ccep.2017.11.003
State	Published - Mar 2018

Keywords

Bradyarrhythmias
Cardiac arrhythmias
Cardiac pacing
Cardiac resynchronization therapy
Leadless pacemaker
Transvenous leads
Transvenous pacemaker

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1016/j.ccep.2017.11.003

Cite this

@article{ce9c067afb7948cc822edb86d055d8d1,

title = "Leadless Pacemakers: State of the Art and Future Perspectives",

abstract = "Leadless pacemaker therapy is a new technology that aims at avoiding lead- and pocket-related complications of conventional transvenous and epicardial pacing. To date, 2 self-contained leadless pacemakers for right ventricular pacing have been clinically available: the Nanostim Leadless Pacemaker System and the Micra Transcatheter Pacing System. Additionally, a new multicomponent leadless pacemaker for endocardial left ventricular pacing has been proposed as an alternative choice for cardiac resynchronization therapy. In this review, we describe the state of the art of leadless pacing and compare the currently available devices with traditional transvenous leadless pacemakers.",

keywords = "Bradyarrhythmias, Cardiac arrhythmias, Cardiac pacing, Cardiac resynchronization therapy, Leadless pacemaker, Transvenous leads, Transvenous pacemaker",

author = "{Della Rocca}, {Domenico G.} and Carola Gianni and {Di Biase}, Luigi and Andrea Natale and Amin Al-Ahmad",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2018",

month = mar,

doi = "10.1016/j.ccep.2017.11.003",

language = "English (US)",

volume = "10",

pages = "17--29",

journal = "Cardiac Electrophysiology Clinics",

issn = "1877-9182",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Leadless Pacemakers

T2 - State of the Art and Future Perspectives

AU - Della Rocca, Domenico G.

AU - Gianni, Carola

AU - Di Biase, Luigi

AU - Natale, Andrea

AU - Al-Ahmad, Amin

PY - 2018/3

Y1 - 2018/3

N2 - Leadless pacemaker therapy is a new technology that aims at avoiding lead- and pocket-related complications of conventional transvenous and epicardial pacing. To date, 2 self-contained leadless pacemakers for right ventricular pacing have been clinically available: the Nanostim Leadless Pacemaker System and the Micra Transcatheter Pacing System. Additionally, a new multicomponent leadless pacemaker for endocardial left ventricular pacing has been proposed as an alternative choice for cardiac resynchronization therapy. In this review, we describe the state of the art of leadless pacing and compare the currently available devices with traditional transvenous leadless pacemakers.

AB - Leadless pacemaker therapy is a new technology that aims at avoiding lead- and pocket-related complications of conventional transvenous and epicardial pacing. To date, 2 self-contained leadless pacemakers for right ventricular pacing have been clinically available: the Nanostim Leadless Pacemaker System and the Micra Transcatheter Pacing System. Additionally, a new multicomponent leadless pacemaker for endocardial left ventricular pacing has been proposed as an alternative choice for cardiac resynchronization therapy. In this review, we describe the state of the art of leadless pacing and compare the currently available devices with traditional transvenous leadless pacemakers.

KW - Bradyarrhythmias

KW - Cardiac arrhythmias

KW - Cardiac pacing

KW - Cardiac resynchronization therapy

KW - Leadless pacemaker

KW - Transvenous leads

KW - Transvenous pacemaker

UR - http://www.scopus.com/inward/record.url?scp=85041858776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041858776&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2017.11.003

DO - 10.1016/j.ccep.2017.11.003

M3 - Review article

C2 - 29428139

AN - SCOPUS:85041858776

SN - 1877-9182

VL - 10

SP - 17

EP - 29

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

IS - 1

ER -

Leadless Pacemakers: State of the Art and Future Perspectives

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this